NCT05461313View on ClinicalTrials.gov

Fully Constrained Acetabular Liner vs. Dual Mobility Hip Joint in the Surgical Treatment of Metastatic Bone Disease of the Hip

NARecruitingINTERVENTIONAL
Enrollment

146

Participants

Timeline

Start Date

September 20, 2022

Primary Completion Date

January 31, 2025

Study Completion Date

July 31, 2026

Conditions
Metastatic Cancer to the Hip
Interventions
OTHER

Constrained Liner

Subjects in this arm will receive a constrained liner with one of the following implants: Freedom Constrained Acetabular Liner (Zimmer Biomet), G7 Freedom Constrained Acetabular Liner (Zimmer Biomet) or Lubinus Acetabular Cup with a safety ring (LINK)

OTHER

Dual Mobility

Subjects in this arm will receive a dual mobility cup with the following implant: Avantage Dual Mobility Cup (Zimmer Biomet)

Trial Locations (1)

2100

RECRUITING

Department of Orthopedic Surgery, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER